Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial isolated dilated cardiomyopathy in which the cause of the disease is a mutation in the ABCC9 gene.
Features include always present findings: Impaired myocardial contractility, Congestive heart failure, Ventricular tachycardia, and Enlarged and weakened heart (dilated cardiomyopathy).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 4 | Impaired myocardial contractility, Congestive heart failure, Ventricular tachycardia |
Age of onset: adulthood.
Cant syndrome is characterized by congenital hypertrichosis; distinctive coarse facial features (including broad nasal bridge, wide mouth with thick vermilion of the upper and lower lips, and macroglossia); enlarged heart with enhanced systolic function or pericardial effusion and, in many, a large patent ductus arteriosus (PDA) requiring repair; and skeletal abnormalities (thickening of the calvaria, broad ribs, scoliosis, and flaring of the metaphyses). Unless noted otherwise, the following description and reported incidence of the phenotypic features associated with this condition is based on 107 individuals with identified pathogenic variants in ABCC9 or KCNJ8 . Table 2. Cant Syndrome: Frequency of Select Features
Feature | % of Personsw/Feature | Comment |
|---|---|---|
Neonatal hypertrichosis | 99% | — |
Cardiovascular findings | Cardiac enlargement | 64% |
PDA | 58% | — |
Dilated aortic root | 32% | — |
Pericardial effusion | 25% | — |
Valvular defects | 18% |
Source: GeneReviews — "Cant Syndrome"
ABCC9 encodes ATP binding cassette subfamily C member 9 (1,549 aa). Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. Highest expression in Uterus (21.8 TPM) and Fallopian Tube (18.3 TPM).
Dilated cardiomyopathy 1O has limited evidence linking it to mutations in the ABCC9 gene on chromosome 12.
The ABCC9 protein participates in ABCC9 L1524Kfs*5 and ABCC9 mutants:KCNJ11 pathways.
ABCC9 is classified as a druggable target (Abc Transporter, Druggable Genome, and Transporter categories) with score 1.2.
127 pathogenic variants reported in ABCC9 in ClinVar, including hotspot variants 1303112 and 31946 (2-star review).
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
1303112 | Conflicting classifications of pathogenicity | — | Yes |
31946 | Pathogenic/Likely pathogenic | 2 stars | Yes |
Current information about genotype-phenotype correlations in Cant syndrome is limited; no significant clinically relevant genotype-phenotype correlations for ABCC9 or KCNJ8 have been identified.
Source: GeneReviews — "Cant Syndrome"
Penetrance for Cant syndrome reported thus far appears to be complete although with variable expression . In a few families, somatic mosaicism for an ABCC9 variant has been identified in one of the parents, resulting in much milder phenotypic manifestations in that individual [; DK Grange, unpublished data].
Source: GeneReviews — "Cant Syndrome"
No formal diagnostic criteria for Cant syndrome have been established.
Cant syndrome should be suspected in probands with the following clinical and imaging findings and family history.
Clinical findings
Congenital hypertrichosis: excess hair growth on scalp, forehead, face, back, and limbs (See and .)
Craniofacial dysmorphic features: coarse facial features, epicanthal folds, broad nasal bridge, anteverted nares, long philtrum, thick vermilion of the upper and lower lips, wide mouth, and macroglossia (See .)
Imaging findings
Source: GeneReviews — "Cant Syndrome"
Genetic Disorders Table 4. Cant Syndrome: Differential Diagnosis
Gene(s)/ Genetic Mechanism | Disorder | MOI | Features of Disorder |
|---|---|---|---|
Beckwith-Wiedemann syndrome | Variable2 | Neonatal macrosomia; full or prominent cheeks; macroglossia; umbilical hernia | Neonatal hypoglycemia hyperinsulinism; ear pits creases; omphalocele; hemihypertrophy; abdominal tumors in childhood (Wilms tumor, hepatoblastoma) ATP6V1B2 KCNH1 |
KCNN3 | Zimmermann-Laband syndrome (OMIM PS135500) |
Genetic testing for ABCC9 is available. Testing is considered research-grade for diagnosis.
No approved treatments are currently available for dilated cardiomyopathy 1O. The disease remains an area of unmet medical need.
No clinical practice guidelines for Cant syndrome have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with Cant syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 5.
Cant Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Cardiology assessment to include echocardiogram electrocardiogram | • Consider cardiac MRI.
Assessment for pulmonary hypertension should be guided by cardiologist as needed.
| • Assessment for headaches seizures
Neurologic exam
EEG if seizures are suspected
|
Brain MRI w/MRA MRV | Should be considered for all persons, but esp if there is history of headaches, migraine headaches, or hemiparesis
| Developmental eval for infants young children |
Neuropsychological eval for older persons | Esp for those w/concern for ASD, ADHD, OCD, or depression
Vascular/
| Assessment for peripheral swelling lymphedema |
GERD | In those w/clinical manifestations of GERD, swallow study might be considered depending on symptoms. |
| • Radiographic skeletal survey as needed to assess for bone abnormalities
Eval for scoliosis
| A full skeletal survey may not be needed in all persons.
Genetic
Source: GeneReviews — "Cant Syndrome"
Avoid the following:
Minoxidil
Diazoxide
Angiotensin-converting enzyme inhibitors
Source: GeneReviews — "Cant Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Cant Syndrome"
View trials for dilated cardiomyopathy 1O
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 7. Cant Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
abnormality | Brain MRI w/MRA MRV | If persistent headaches or other neurologic symptoms develop |
Development | Monitor developmental progress educational needs. | At each visit |
Peripheral edema/lymphedema | Monitor w/history exam. | Annually starting in adolescence |
GERD | Assessment for GERD | As needed |
Neurobehavioral/Psychiatric | Assessment for ADHD, ASD, OCD, anxiety, depression | At each visit Scoliosis |
Source: GeneReviews — "Cant Syndrome"
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for dilated cardiomyopathy 1O.
2 publications have been identified in PubMed for dilated cardiomyopathy 1O. Research spans Basic Science / Preclinical (100%).
Younus I (2025). [PMID: 39852261](https://pubmed.ncbi.nlm.nih.gov/39852261/). *Membranes (Basel)*. [Basic Science / Preclinical]
Shen J (2025). [PMID: 40948388](https://pubmed.ncbi.nlm.nih.gov/40948388/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Tortuous vascularity | 100% (10/10) on neurovascular imaging | True prevalence of this feature is unknown. |
In 1 study all persons evaluated by neurovascular imaging had this finding in head neck.1 Hypotonia | 65% | — |
Developmental delays | 63% | Present in infants young children; Related to hypotonia but improves over time |
Most have normal intellect Peripheral edema | 51% | Usually develops in teenagers young adults |
Macrocephaly | 48% | Of adults studied |
Gastroesophageal reflux | 42% | — |
Headaches | 40% | Often migraine-type headache w/assoc symptoms |
Pulmonary hypertension | 24% | Seen in infancy; Typically resolves w/age |
Can occur in older persons Seizures | 24% | Various types |
Behavioral issues2 | ADHD | 19% |
ASD | 16% | — |
OCD | 13% | — |
Anxiety | 13% | — |
Depression | 19% | — |
Skeletal abnormalities | 19% | Usually asymptomatic so detection dependent on imaging ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder; OCD = obsessive-compulsive disorder; PDA = patent ductus arteriosus 1. 2. Prenatal/neonatal. |
AD |
Hypertrichosis; coarse facial features; thick vermilion of upper lower lips; macrosomia at birth; PDA; aortic root dilatation; scoliosis; hypotonia |
BSCL2 | Berardinelli-Seip congenital lipodystrophy (BSCL) | AR | Athletic appearance (due to lipoatrophy skeletal muscle hypertrophy in BSCL); cardiomegaly (caused by hypertrophic cardiomyopathy in BSCL) |
Nonsyndromic hypertrophic cardiomyopathy | ADAR | Cardiomegaly | Absence of noncardiac findings(Note: Persons w/Cant syndrome have normal ventricular wall thickness normal or enhanced myocardial function [despite enlargement of cardiac chambers] high cardiac output.) 40 genesincl:4BAG3DESFLNCLMNAMYH7PLNRBM20SCN5ATNNC1TNNT2TTN |
KCNK4 | FHEIG syndrome (Bauer-Tartaglia syndrome) (OMIM 618381) | AD | Hypertrichosis; coarse facial features; thick scalp hair; wide mouth; hypotonia |
GALNS | Mucopolysaccharidosis type IVA (Morquio syndrome type A) | AR | Coarse facial features hirsutism; some skeletal radiologic features (e.g., thickening of ribs) |
GNPTAB | Mucolipidosis III/ (See GNPTAB Disorders.) | AR GNPTG | Mucolipidosis III gamma |
IDS | Mucopolysaccharidosis type II (Hunter syndrome) | XL | — |
IDUA | Severe Mucopolysaccharidosis type I | AR MAN2B1 | Alpha-mannosidosis AD = autosomal dominant; AR = autosomal recessive; CNV = copy number variant; DD = developmental delay; FHEIG syndrome = facial dysmorphism, hypertrichosis, epilepsy, intellectual/... |
Source: GeneReviews — "Cant Syndrome"